
Analysis and Discussion of Common Problems in the Pre-approval Inspection of Heparin Drugs
HU Xiaojuan
Analysis and Discussion of Common Problems in the Pre-approval Inspection of Heparin Drugs
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |